Popular Stories

• 

  Gilead’s remdesivir enters China phase III trial to fight coronavirus

  BioWorld

  BEIJING – China will kickstart a phase III trial Feb. 3 to determine whether patients with 2019-nCoV can be treated with Gilead Sciences Inc.’s NUC inhibitor,...

• 

  Coronavirus: Chinese researchers claim TCM herbal remedy could ‘inhibit’ 2019-nCoV

  BioWorld

  HONG KONG – In another example that communication is proving as difficult as containment in the current coronavirus outbreak, China’s state media reported, to...

• 

  Hong Kong researchers create fastest coronavirus diagnostic test to date

  BioWorld

  HONG KONG – A team of researchers at Hong Kong University of Science and Technology (HKUST) claim to have invented the world’s fastest portable 2019-nCoV...

• 

  Hong Kong researchers develop coronavirus vaccine

  BioWorld

  HONG KONG – As drug developers are racing to find a cure for the new coronavirus, researchers in Hong Kong claim to have made major headway in the development of...

• 

  In China, the race is on to develop, approve test kits for coronavirus

  BioWorld MedTech

  BEIJING – Chinese regulators are speeding up to approve more test kits for the deadly coronavirus that already has killed 170 people and infected more than 7,700...